365 related articles for article (PubMed ID: 30719548)
1. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
Ahn SH; Kim JH; Cho YY; Suh S; Kim BJ; Hong S; Lee SH; Koh JM; Song KH
Osteoporos Int; 2019 May; 30(5):1059-1069. PubMed ID: 30719548
[TBL] [Abstract][Full Text] [Related]
2. The association of cortisol and adrenal androgen with trabecular bone score in patients with adrenal incidentaloma with and without autonomous cortisol secretion.
Kim BJ; Kwak MK; Ahn SH; Kim JS; Lee SH; Koh JM
Osteoporos Int; 2018 Oct; 29(10):2299-2307. PubMed ID: 29971455
[TBL] [Abstract][Full Text] [Related]
3. The association between serum dehydroepiandrosterone Sulphate (DHEA-S) level and bone mineral density in Korean men.
Lee D; Kim H; Ahn SH; Lee SH; Bae SJ; Kim EH; Kim HK; Choe JW; Kim BJ; Koh JM
Clin Endocrinol (Oxf); 2015 Aug; 83(2):173-9. PubMed ID: 25692973
[TBL] [Abstract][Full Text] [Related]
4. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
5. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
[TBL] [Abstract][Full Text] [Related]
6. Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?
Hadjidakis D; Tsagarakis S; Roboti C; Sfakianakis M; Iconomidou V; Raptis SA; Thalassinos N
Clin Endocrinol (Oxf); 2003 Jan; 58(1):72-7. PubMed ID: 12519415
[TBL] [Abstract][Full Text] [Related]
7. Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma.
Francucci CM; Pantanetti P; Garrapa GG; Massi F; Arnaldi G; Mantero F
Clin Endocrinol (Oxf); 2002 Nov; 57(5):587-93. PubMed ID: 12390331
[TBL] [Abstract][Full Text] [Related]
8. Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism.
Eller-Vainicher C; Morelli V; Ulivieri FM; Palmieri S; Zhukouskaya VV; Cairoli E; Pino R; Naccarato A; Scillitani A; Beck-Peccoz P; Chiodini I
J Bone Miner Res; 2012 Oct; 27(10):2223-30. PubMed ID: 22549969
[TBL] [Abstract][Full Text] [Related]
9. Alteration in skeletal muscle mass in women with subclinical hypercortisolism.
Kim JH; Kwak MK; Ahn SH; Kim H; Cho YY; Suh S; Kim BJ; Song KH; Lee SH; Koh JM
Endocrine; 2018 Jul; 61(1):134-143. PubMed ID: 29717464
[TBL] [Abstract][Full Text] [Related]
10. Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism.
Tauchmanovà L; Pivonello R; De Martino MC; Rusciano A; De Leo M; Ruosi C; Mainolfi C; Lombardi G; Salvatore M; Colao A
Eur J Endocrinol; 2007 Sep; 157(3):359-66. PubMed ID: 17766720
[TBL] [Abstract][Full Text] [Related]
11. Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal non-osteoporotic women in the early postmenopausal period.
Osella G; Ventura M; Ardito A; Allasino B; Termine A; Saba L; Vitetta R; Terzolo M; Angeli A
Eur J Endocrinol; 2012 May; 166(5):855-60. PubMed ID: 22312036
[TBL] [Abstract][Full Text] [Related]
12. Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures.
Chiodini I; Viti R; Coletti F; Guglielmi G; Battista C; Ermetici F; Morelli V; Salcuni A; Carnevale V; Urbano F; Muscarella S; Ambrosi B; Arosio M; Beck-Peccoz P; Scillitani A
Clin Endocrinol (Oxf); 2009 Feb; 70(2):208-13. PubMed ID: 18547342
[TBL] [Abstract][Full Text] [Related]
13. Bone Evaluation by High-Resolution Peripheral Quantitative Computed Tomography in Patients With Adrenal Incidentaloma.
Moraes AB; de Paula MP; de Paula Paranhos-Neto F; Cavalari EMR; de Morais FFC; Curi DSC; Lima LFC; de Mendonça LMC; Farias MLF; Madeira M; Vieira Neto L
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32413110
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids.
Ebeling PR; Erbas B; Hopper JL; Wark JD; Rubinfeld AR
J Bone Miner Res; 1998 Aug; 13(8):1283-9. PubMed ID: 9718197
[TBL] [Abstract][Full Text] [Related]
15. Associations of dietary calcium intake with metabolic syndrome and bone mineral density among the Korean population: KNHANES 2008-2011.
Kim MK; Chon SJ; Noe EB; Roh YH; Yun BH; Cho S; Choi YS; Lee BS; Seo SK
Osteoporos Int; 2017 Jan; 28(1):299-308. PubMed ID: 27503170
[TBL] [Abstract][Full Text] [Related]
16. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women.
Makker A; Singh MM; Mishra G; Singh BP; Jain GK; Jadhav S
Menopause; 2012 Jun; 19(6):642-9. PubMed ID: 22240638
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density and bone turnover in relation to serum leptin, alpha-ketoglutarate and sex steroids in overweight and obese postmenopausal women.
Filip R; Raszewski G
Clin Endocrinol (Oxf); 2009 Feb; 70(2):214-20. PubMed ID: 18547340
[TBL] [Abstract][Full Text] [Related]
18. Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.
Olsen H; Nordenström E; Bergenfelz A; Nyman U; Valdemarsson S; Palmqvist E
Endocrine; 2012 Aug; 42(1):164-73. PubMed ID: 22350586
[TBL] [Abstract][Full Text] [Related]
19. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
20. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
Khawandanah D; ElAsmar N; Arafah BM
Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
